136
Participants
Start Date
April 4, 2023
Primary Completion Date
February 21, 2024
Study Completion Date
February 21, 2024
ONL1204 Ophthalmic Solution
ONL1204 Ophthalmic Solution at one of two doses delivered via intravitreal injection
Sham treatment
Sham injection is performed by touching the eye surface with a syringe without a needle
Retina Vitreous Surgeons of CNY, PC, Liverpool
Retina Associates of Western NY, PC, Rochester
Erie Retina Research, LLC, Erie
Cumberland Valley Retina Consultants, Hagerstown
Palmetto Retina Center, LLC, West Columbia
Charleston Neuroscience Institute, Ladson
Marietta Eye Clinic, Marietta
Florida Retina Institute, Jacksonville
Retina Specialty Institute, Pensacola
Retina Specialists of Tampa, Wesley Chapel
Retina Vitreous Associates of Florida, St. Petersburg
Florida Retina Consultants, Lakeland
Sarasota Retina Institute, Sarasota
Southeastern Retina Associates, Chattanooga
Charles Retina Institute, Germantown
Velocity Clinical Research, Inc., Cincinnati
Midwest Eye Institute, Carmel
University of Michigan Kellogg Eye Center, Ann Arbor
Mayo Clinic, Rochester
Opthalmology Ltd, Sioux Falls
Retina Associates, Ltd., Elmhurst
Retina Associates, Ltd, Elmhurst
The Retina Institute, St Louis
Retina Consultants of Texas, The Woodlands
Retina Consultants of Texas, Beaumont
San Antonio Eye Center, San Antonio
Valley Retina Institute, P.A., McAllen
Austin Research Center for Retina, Austin
Retina Research Institute of Texas, Abilene
Associated Retina Consultants, Phoenix
Retina Associates SW PC, Tucson
Win Retina, Arcadia
Global Research Management, Inc., Glendale
Salehi Retina Institute, Inc., Huntington Beach
Oregon Health & Science University - Casey Eye Institute, Portland
Retina Center NW, PLLC, Silverdale
Lead Sponsor
ONL Therapeutics
INDUSTRY